A new study suggests Pfizer’s vaccine is effective against the new coronavirus strains that are quickly spreading in Britain and South Africa.
A new study suggests Pfizer’s vaccine is effective against the new coronavirus strains that are quickly spreading in Britain and South Africa.
Johnson & Johnson announced Friday that its single-dose vaccine was 66% effective globally in preventing COVID-19, and 72%..